Universal Ibogaine Overview
- Year Founded
-
2017
- Status
-
Public
- Employees
-
14
- Stock Symbol
-
IBO
- Investments
-
3
Universal Ibogaine General Information
Description
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment.
Contact Information
Website
www.universalibogaine.comCorporate Office
- Suite 1470, Devon Tower
- 400 3rd Avenue South West
- Calgary, Alberta T2P 4H2
- Canada
Corporate Office
- Suite 1470, Devon Tower
- 400 3rd Avenue South West
- Calgary, Alberta T2P 4H2
- Canada
Universal Ibogaine Timeline
Universal Ibogaine Stock Performance
As of 02-Feb-2026, Universal Ibogaine’s current market cap is $1.15M with 313M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.15M | 313M | 498K | -$0.01 |
Universal Ibogaine Financials Summary
As of 30-Apr-2025, Universal Ibogaine has a trailing 12-month revenue of $1.48M.
|
In Thousands, USD |
TTM 30-Apr-2025 | FY 2024 31-Jul-2024 | FY 2023 31-Jul-2023 | FY 2022 31-Jul-2022 |
|---|---|---|---|---|
| EV | 7,818 | 5,002 | 3,901 | 5,883 |
| Revenue | 1,476 | 1,715 | 767 | 843 |
| EBITDA | (699) | (1,137) | (1,471) | (8,001) |
| Net Income | (1,057) | (1,509) | (1,779) | (8,264) |
| Total Assets | 2,897 | 3,258 | 4,151 | 4,874 |
| Total Debt | 1,859 | 1,916 | 2,095 | 1,341 |
Universal Ibogaine Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Universal Ibogaine Signals
Universal Ibogaine Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Universal Ibogaine Acquisitions (3)
Universal Ibogaine’s most recent deal was a Merger/Acquisition with P Squared Renewables. The deal was made on 02-Sep-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| P Squared Renewables | 02-Sep-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| Kelburn Recovery Centre | 31-Aug-2021 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Universal Ibogaine Belize | 01-Jan-2020 | Merger/Acquisition | Holding Companies |
Universal Ibogaine ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Universal Ibogaine Exits (1)
Universal Ibogaine’s most recent exit was on 01-Jan-2020 from Universal Ibogaine Belize. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Universal Ibogaine Belize | 01-Jan-2020 | Completed |
|
Universal Ibogaine Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Kelburn Recovery Centre | Winnipeg, Canada | 2014 |
Universal Ibogaine FAQs
-
When was Universal Ibogaine founded?
Universal Ibogaine was founded in 2017.
-
Where is Universal Ibogaine headquartered?
Universal Ibogaine is headquartered in Calgary, Canada.
-
What is the size of Universal Ibogaine?
Universal Ibogaine has 14 total employees.
-
What industry is Universal Ibogaine in?
Universal Ibogaine’s primary industry is Other Healthcare Services.
-
Is Universal Ibogaine a private or public company?
Universal Ibogaine is a Public company.
-
What is Universal Ibogaine’s stock symbol?
The ticker symbol for Universal Ibogaine is IBO.
-
What is the current market cap of Universal Ibogaine?
The current market capitalization of Universal Ibogaine is $1.15M.
-
What is Universal Ibogaine’s current revenue?
The trailing twelve month revenue for Universal Ibogaine is $1.48M.
-
What is Universal Ibogaine’s annual earnings per share (EPS)?
Universal Ibogaine’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process